Edition:
United States

Insider Trading: Celgene Corp (CELG.O)

CELG.O on Nasdaq

143.89USD
22 Sep 2017
Change (% chg)

$0.11 (+0.08%)
Prev Close
$143.78
Open
$143.31
Day's High
$144.19
Day's Low
$141.75
Volume
3,549,466
Avg. Vol
3,783,014
52-wk High
$144.59
52-wk Low
$96.93

All Insider Trades
Trading Date Name Title Type Shares Traded Price
11 Sep 2017

Kaplan (Gilla)

Director Buy 9,250 $33.88
11 Sep 2017

Kaplan (Gilla)

Director Sell 9,250 $141.56
4 Sep 2017

Casey (Michael D)

Director Buy 9,250 $24.97
4 Sep 2017

Casey (Michael D)

Director Sell 9,250 $139.03
9 Aug 2017

Mario (Ernest B Ph.D.)

Director Sell 18,506 $130.52
1 Aug 2017

Kaplan (Gilla)

Director Sell 7,500 $134.52
31 Jul 2017

Kellogg (Peter N)

Chief Financial Officer Sell 31,110 $135.18
31 Jul 2017

Curran (Terrie)

Officer Sell 558 $135.18
31 Jul 2017

Curran (Terrie)

Officer Buy 1,500 $0.00
31 Jul 2017

Kellogg (Peter N)

Chief Financial Officer Buy 60,000 $0.00
27 Jul 2017

Hugin (Robert J)

Officer and Director Sell 23,073 $134.10
27 Jul 2017

Pehl (Michael F)

Officer Buy 2,500 $0.00
27 Jul 2017

Alles (Mark J)

Chief Executive Officer Buy 4,200 $0.00
27 Jul 2017

Pehl (Michael F)

Officer Sell 1,125 $134.10
27 Jul 2017

Hugin (Robert J)

Officer and Director Buy 44,500 $0.00
27 Jul 2017

Smith Scott Andrew

President Sell 2,592 $134.10
27 Jul 2017

Alles (Mark J)

Chief Executive Officer Sell 1,932 $134.10
27 Jul 2017

Smith Scott Andrew

President Buy 5,000 $0.00
30 Jun 2017

Friedman (Michael A)

Director Buy 734 $0.00
30 Jun 2017

Casey (Michael D)

Director Buy 734 $0.00
30 Jun 2017

Barker (Richard William)

Director Sell 220 $129.87
30 Jun 2017

Barker (Richard William)

Director Buy 734 $0.00
30 Jun 2017

Loughlin (James J)

Director Buy 734 $0.00
30 Jun 2017

Kaplan (Gilla)

Director Buy 734 $0.00
30 Jun 2017

Mario (Ernest B Ph.D.)

Director Buy 734 $0.00

Institutional Holders

% Shares Owned: 81.62%
# of Holders: 1,929
Total Shares Held: 638,583,111
3 Mo. Net Change: 11,778,782
# New Positions: 117
# Closed Positions: 75
# Increased Positions: 848
# Reduced Positions: 661
# Net Buyers: 187

Officers & Directors

Name Age Since Current Position

Robert Hugin

62 2016 Executive Chairman of the Board

Scott Smith

55 2017 President, Chief Operating Officer

Mark Alles

58 2016 Chief Executive Officer, Director

Peter Kellogg

61 2014 Chief Financial Officer, Executive Vice President

Terrie Curran

48 2017 President, Global Inflammation & Immunology Franchise

Michael Pehl

52 2016 President, Hematology & Oncology

Rupert Vessey

52 2016 President - Research and Early Development

Gerald Masoudi

49 Executive Vice President, General Counsel and Corporate Secretary

Michael Casey

71 2007 Lead Independent Director

Michael Bonney

58 2015 Director

Julia Haller

62 2015 Director

Richard Barker

68 2012 Independent Director

Carrie Cox

59 2009 Independent Director

Michael Friedman

73 2011 Independent Director

Gilla Kaplan

70 1998 Independent Director

James Loughlin

74 2007 Independent Director

Ernest Mario

78 2007 Independent Director